Hid is committed to advancing research in critical areas of Red Biotech, our research fields of interest are described below.
Pioneering new approaches to improve blood clotting processes and treatments for bleeding disorders.
Exploring new therapeutic strategies to manage and treat diseases caused by immune system and inflammatory responses.
Advancing the next generation of immunotherapies to fight cancer and other diseases by harnessing the body’s immune system.
Developing innovative treatments to address various forms of anemia, enhancing patient vitality and health.
At the core of Hid’s approach is our commitment to collaboration. By uniting a diverse range of experts from academia, clinical practice, and the biotech industry, we foster a multidisciplinary environment that is conducive to breakthroughs and rapid advancements in Red Biotech.
We cultivate a vibrant ecosystem, promoting synergy through collaborations among students, researchers, startups, and industry partners.
We form strategic partnerships with industry leaders, investors, and government bodies to accelerate innovation and drive economic growth.
We invest in advanced facilities and resources, including labs and coworking spaces, to foster innovation in health solutions.
We enhance our community through active engagement, organizing events and networking opportunities that foster a collaborative environment.
The Sanquin Academy and related initiatives prepare emerging talents with essential skills in entrepreneurship and innovation.
Our commitment to sustainability includes green building practices, renewable energy, and waste reduction efforts to ensure a sustainable future.
Our research centers focus on societal challenges and sustainable development, driving impactful advancements in health and technology.
Whether you’re a scientist, entrepreneur, or student, the Hid offers a perfect environment to push boundaries and contribute to life-changing advancements in anemia, immunotherapy, and bleeding disorders.